Sinclair Pharma Regulatory News (SPH)

30 April 2014

Director's Dealing

Sinclair IS Pharma plc (SPH.L), ("Sinclair" or the "Group") the international specialty pharma company, was informed on 29 April 2014 that earlier that day Stuart Swanson, a Non-Executive Director, acquired 154,225 ordinary shares in Sinclair at a price of 30.75p per share. Following this purchase Stuart Swanson has a beneficial interest in 4,522,854 ordinary shares representing 1.04% of the Group's issued ordinary share capital. For the avoidance of doubt this holding excludes the 3,125,000 Placing Shares that Stuart Swanson is subscribing for as part of the Placing announced on 15 April 2014 which is due to complete on 2 May 2014.

For further information, please contact:

Sinclair IS Pharma plc Tel: +44 (0) 20 7467 6920

Chris Spooner

Alan Olby

Robert Taylor

Peel Hunt LLP Tel: +44 (0) 20 7418 8900

James Steel

Clare Terlouw